Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial
Trials
.
2020 Jun 22;21(1):554.
doi: 10.1186/s13063-020-04520-x.
Authors
Cedric Bosteels
1
,
Bastiaan Maes
2
,
Karel Van Damme
1
,
Elisabeth De Leeuw
1
,
Jozefien Declercq
1
,
Anja Delporte
1
,
Bénédicte Demeyere
1
,
Stéfanie Vermeersch
1
,
Marnik Vuylsteke
1
,
Joren Willaert
1
,
Laura Bollé
1
,
Yuri Vanbiervliet
1
,
Jana Decuypere
1
,
Frederick Libeer
1
,
Stefaan Vandecasteele
1
,
Isabelle Peene
1
,
Bart N Lambrecht
1
Affiliations
1
VIB-UGent Inflammatie-researchcentrum, Oost-Vlaanderen, Ghent, Belgium.
2
VIB-UGent Inflammatie-researchcentrum, Oost-Vlaanderen, Ghent, Belgium. bastiaan.maes@irc.vib-ugent.be.
PMID:
32571428
PMCID:
PMC7306655
DOI:
10.1186/s13063-020-04520-x
Abstract
An amendment to this paper has been published and can be accessed via the original article.
Publication types
Published Erratum